Recurrence of Hepatocellular Cancer after Resection: Patterns, Treatments, and Prognosis

Annals of Surgery

Volumn 261, Issue 5, 2015, Pages 947-955

  Tabrizian, Parissa ^a   Jibara, Ghalib ^b   Shrager, Brian ^c   Schwartz, Myron ^a   Roayaie, Sasan ^d  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b Department of Urology   (United States)

^c MORRISTOWN MEDICAL CENTER   (United States)

^d LENOX HILL HOSPITAL   (United States)

Author keywords

hepatocellular; outcomes; prognosis; recurrence; resection; treatments

Indexed keywords

ABLATION THERAPY; ALGORITHM; ARTIFICIAL EMBOLISM; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMAN; LIVER NEOPLASMS; LIVER RESECTION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; REOPERATION; SURVIVAL; THERAPY; TIME; TUMOR INVASION; TUMOR RECURRENCE;

ABLATION TECHNIQUES; ALGORITHMS; CARCINOMA, HEPATOCELLULAR; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; REOPERATION; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 84936871814     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000710     Document Type: Article

References (27)

1. Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 2005; 42: 1208-1236.
2. European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012; 56: 908-943.
3. Roayaie S, Obeidat K, Sposito C, Resection of hepatocellular cancer ≤2 cm: results from two Western centers. Hepatology. 2013; 57: 1426-1435.
4. Lee PH, Lin WJ, Tsang YM, Clinical management of recurrent hepatocellular carcinoma. Ann Surg. 1995; 222: 670-676.
5. Poon RT, Fan ST, Lo CM, Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg. 1999; 229: 216-222.
6. Chen WT, Chau GY, Lui WY, Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcome. Eur J Surg Oncol. 2004; 30: 414-420.
7. Shah SA, Cleary SP, Wei AC, Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. Surgery. 2007; 141: 330-339.
8. Ho CM, Lee PH, Shau WY, Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy: comparative effectiveness of treatment modalities. Surgery. 2012; 151: 700-709.
9. Kishi Y, Saiura A, Yamamoto J, Repeat treatment for recurrent hepatocellular carcinoma: is it validated? Langenbecks Arch Surg. 2011; 396: 1093-1100.
10. Tranchart H, Chirica M, Sepulveda A, Long-term outcomes following aggressive management of recurrent hepatocellular carcinoma after upfront liver resection. World J Surg. 2012; 36: 2684-2691.
11. Cha C, Fong Y, Jarnagin WR, Predictors and patterns of recurrence after resection of hepatocellular carcinoma. J Am Coll Surg. 2003; 197: 753-758.
12. Imamura H, Matsuyama Y, Tanaka E, Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 2003; 38: 200-207.
13. Fong Y, Fortner J, Sun RL, Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999; 230: 309-318; discussion 318-321.
14. Petrowsky H, Gonen M, Jarnagin W, Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg. 2002; 235: 863-871.
15. Roayaie S, Bassi D, Tarchi P, Second hepatic resection for recurrent hepatocellular cancer: a Western experience. J Hepatol. 2011; 55: 346-350.
16. Llovet JM, Schwartz M, Mazzaferro V,. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis. 2005; 25: 181-200.
17. Llovet JM, Fuster J, Bruix J,. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999; 30: 1434-1440.
18. Pelletier SJ, Fu S, Thyagarajan V, An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data. Liver Transpl. 2009; 15: 859-868.
19. Sogawa H, Shrager B, Jibara G, Resection or transplant-listing for solitary hepatitis C-associated hepatocellular carcinoma: an intention-to-treat analysis. HPB (Oxford). 2013; 15: 134-141.
20. Fuks D, Dokmak S, Paradis V, Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis. Hepatology. 2012; 55: 132-140.
21. Sala M, Llovet JM, Vilana R, Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology. 2004; 40: 1352-1360.
22. Llovet JM, Ricci S, Mazzaferro V, Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008; 359: 378-390.
23. Llovet JM, Real MI, Montana X, Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002; 359: 1734-1739.
24. Malagari K, Alexopoulou E, Chatzimichail K, Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead. Abdom Imaging. 2008; 33: 512-519.
25. Takayasu K, Arii S, Ikai I, Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis. AJR Am J Roentgenol. 2010; 194: 830-837.
26. Kim KM, Kim JH, Park IS, Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion. J Gastroenterol Hepatol. 2009; 24: 806-814.
27. Jin YJ, Lee JW, Lee OH, Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion. J Gastroenterol. 2014; 29: 1056-1064.